Adverum Biotechnologies
ADVM
ADVM
86 hedge funds and large institutions have $121M invested in Adverum Biotechnologies in 2018 Q4 according to their latest regulatory filings, with 14 funds opening new positions, 26 increasing their positions, 24 reducing their positions, and 28 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
more funds holding in top 10
Funds holding in top 10: →
15% less funds holding
Funds holding: 101 → 86 (-15)
50% less first-time investments, than exits
New positions opened: 14 | Existing positions closed: 28
55% less capital invested
Capital invested by funds: $269M → $121M (-$148M)
Holders
86
Holding in Top 10
1
Calls
$129K
Puts
$52K
Top Buyers
| 1 | +$19.1M | |
| 2 | +$3.61M | |
| 3 | +$2.68M | |
| 4 |
BlackRock
New York
|
+$2.37M |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$2.2M |
Top Sellers
| 1 | -$60.5M | |
| 2 | -$11.3M | |
| 3 | -$6.55M | |
| 4 |
RSCM
Rock Springs Capital Management
Baltimore,
Maryland
|
-$5.45M |
| 5 |
Alkeon Capital Management
New York
|
-$4.95M |